1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 142 pages

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hodgkin Lymphoma Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hodgkin Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hodgkin Lymphoma 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Hodgkin Lymphoma Therapeutics Clinical Trials 37
Prominent Drugs 38
Latest Clinical Trials News on Hodgkin Lymphoma 39
Jun 17, 2015: Seattle Genetics Announces Multiple ADCETRIS (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma 39
May 31, 2015: Curis Reports CUDC-907 Data From the Ongoing Phase 1 Trial at the 2015 ASCO Annual Meeting 40
May 29, 2015: Cellular Biomedicine Group to Provide Business and Clinical Updates at Jefferies 2015 Global Healthcare Conference 41
May 22, 2015: Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program 41
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
Seattle Genetics, Inc. 43
Clinical Trial Overview of Seattle Genetics, Inc. 43
Takeda Pharmaceutical Company Limited 46
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 46
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Bristol-Myers Squibb Company 52
Clinical Trial Overview of Bristol-Myers Squibb Company 52
Sanofi 53
Clinical Trial Overview of Sanofi 53
Merck and Co., Inc. 55
Clinical Trial Overview of Merck and Co., Inc. 55
F. Hoffmann-La Roche Ltd. 56
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 56
Amgen Inc. 57
Clinical Trial Overview of Amgen Inc. 57
AbbVie Inc. 58
Clinical Trial Overview of AbbVie Inc. 58
Clinical Trial Overview of Top Institutes / Government 59
National Cancer Institute 59
Clinical Trial Overview of National Cancer Institute 59
Fred Hutchinson Cancer Research Center 78
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 78
The University of Texas M. D. Anderson Cancer Center 82
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 82
Memorial Sloan Kettering Cancer Center 85
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 85
Baylor College of Medicine 87
Clinical Trial Overview of Baylor College of Medicine 87
University of Cologne 89
Clinical Trial Overview of University of Cologne 89
Children's Oncology Group 91
Clinical Trial Overview of Children's Oncology Group 91
Stanford University 93
Clinical Trial Overview of Stanford University 93
Case Comprehensive Cancer Center 94
Clinical Trial Overview of Case Comprehensive Cancer Center 94
Massachusetts General Hospital 95
Clinical Trial Overview of Massachusetts General Hospital 95
Five Key Clinical Profiles 96
Appendix 139
Abbreviations 139
Definitions 139
Research Methodology 140
Secondary Research 140
About GlobalData 141
Contact Us 141
Disclaimer 141
Source 142

List of Tables
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hodgkin Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Hodgkin Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Hodgkin Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 34
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 35
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 36
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 37
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 38
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2015* 43
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 46
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 48
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 50
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 52
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 53
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 55
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 56
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 57
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 58
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 59
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 78
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2015* 82
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 85
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 87
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2015* 89
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015* 91
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 93
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 94
Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 95

List of Figures
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 34
Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 35
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 36
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 37
Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 38
GlobalData Methodology 140

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma o ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in Russia

  • November 2016
    8 pages
  • Leukemia  

    Cancer  

    Radiography  

  • Russian Federat...  

View report >

Colorectal Cancer Statistics in the US - Forecast

  • November 2016
    14 pages
  • Colorectal Canc...  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.